Showing results (1-10 of 33) with videos related to
Sort By:
Pageof 4
Annals of Hematology|November 10, 2006
Long-term follow-up of allogeneic HSCT for CML reveals significant improvement in the outcome over the last decadeMartin Weisser, Georg Ledderose, Hans Jochem KolbLeukemia & Lymphoma|October 11, 2007
Advanced age and high initial WBC influence the outcome of inv(3) (q21q26)/t(3;3) (q21;q26) positive AMLMartin Weisser, Claudia Haferlach, Torsten Haferlach, et al.Cancer Treatment Reviews|June 27, 2018
Clinical development of HER3-targeting monoclonal antibodies: Perils and progressWolfgang Jacob, Ian James, Max Hasmann, et al.Cancer Genetics and Cytogenetics|August 19, 2007
Feasibility of using the combined MDS-EVI1/EVI1 gene expression as an alternative molecular marker in acute myeloid leukemia: a report of four casesMartin Weisser, Claudia Haferlach, Torsten Haferlach, et al.Journal of Clinical Bioinformatics|May 7, 2013
An optimized workflow for improved gene expression profiling for formalin-fixed, paraffin-embedded tumor samplesMarlene Thomas, Manuela Poignée-Heger, Martin Weisser, et al.Leukemia & Lymphoma|February 28, 2007
Allogeneic stem-cell transplantation provides excellent results in advanced stage chronic myeloid leukemia with major cytogenetic response to pre-transplant imatinib therapyMartin Weisser, Michael Schleuning, Claudia Haferlach, et al.Blood|July 5, 2003
New score predicting for prognosis in PML-RARA+, AML1-ETO+, or CBFBMYH11+ acute myeloid leukemia based on quantification of fusion transcriptsSusanne Schnittger, Martin Weisser, Claudia Schoch, et al.Haematologica|July 6, 2005
Risk assessment by monitoring expression levels of partial tandem duplications in the MLL gene in acute myeloid leukemia during therapyMartin Weisser, Wolfgang Kern, Claudia Schoch, et al.Haematologica|April 22, 2006
A comparison of donor lymphocyte infusions or imatinib mesylate for patients with chronic myelogenous leukemia who have relapsed after allogeneic stem cell transplantationMartin Weisser, Johanna Tischer, Susanne Schnittger, et al.Cancer Genetics and Cytogenetics|July 18, 2006
Acute myeloid leukemia (AML) with t(8;21)(q22;q22) relapsing as AML with t(3;21)(q26;q22)Ulrike Bacher, Susanne Schnittger, Wolfgang Kern, et al.Pageof 4